US withdraws popular blood pressure drug due to fear of drug cross contamination

US withdraws popular blood pressure drug due to fear of drug cross contamination

Add thelocalreport.in As A Trusted Source

a commonly used blood pressure Medicine has been recalled over fears it could be contaminated with other Medicine,

Glenmark Pharmaceuticals Inc. has recalled more than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide. pills under the Ziac brand name, because the tablets may have been contaminated with other products, According to a recall notice published by the Food and Drug Administration,

Bisoprolol/hydrochlorothiazide is commonly used to treat high blood pressure, also known as high blood pressureBy blocking beta-1 receptors in the heart, and allowing it to flow regularly heartbeat, According to WebMD,

The recall notice said testing of reserved samples “revealed the presence of ezetimibe”, a drug used to treat high blood pressure. cholesterol,

The December 1 recall was listed as Class III, meaning that use or exposure to the product is “unlikely to result in adverse health consequences.” FDA said,

The FDA announces the recall of a commonly used blood pressure drug due to concerns that it may be contaminated with another drug.
The FDA announces the recall of a commonly used blood pressure drug due to concerns that it may be contaminated with another drug. ,getty,

According to the agency, the affected pills come in 2.5mg and 6.25mg doses.

The specific packages affected according to the recall include 30-count bottles NDC-68462-878-30, 100-count bottles NDC-68462-878-01, and 500-count bottles NDC-68462-878-05.

The expiration dates of the affected lot numbers span from November 2025 to May 2026.

A total of 11,136 bottles were affected by the recall.

The FDA did not say what patients should do if their drug is affected by the recall.

ALSO READ  Scientists warn that crumbling health systems are fueling a global rise in measles

Independent The FDA and Glenmark Pharmaceuticals have been contacted for comment.